Related references
Note: Only part of the references are listed.Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation
Jurgen B. Langenhorst et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
Population Pharmacokinetics of Clofarabine as Part of Pretransplantation Conditioning in Pediatric Subjects before Hematopoietic Cell Transplantation
Hechuan Wang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Jurgen B. Langenhorst et al.
CLINICAL PHARMACOKINETICS (2019)
Fludarabine exposure in the conditioning prior to allogeneic hematopoietic cell transplantation predicts outcomes
J. B. Langenhorst et al.
BLOOD ADVANCES (2019)
Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC-MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning
Arjen. M. Punt et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
An automated sampling importance resampling procedure for estimating parameter uncertainty
Anne-Gaelle Dosne et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2017)
Pharmacokinetic models of morphine and its metabolites in neonates: Systematic comparisons of models from the literature, and development of a new meta-model
Katrine Rorbaek Knosgaard et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis
Imke H. Bartelink et al.
Lancet Haematology (2016)
Population Pharmacokinetic Modeling of Thymoglobulin (R) in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing
Rick Admiraal et al.
CLINICAL PHARMACOKINETICS (2015)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Clofarabine ± Fludarabine with Once Daily i.v. Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS
Borje S. Andersson et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer
Peter L. Bonate et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Pirana and PCluster: A modeling environment and cluster infrastructure for NONMEM
Ron J. Keizer et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2011)
Human renal function maturation: a quantitative description using weight and postmenstrual age
Malin M. Rhodin et al.
PEDIATRIC NEPHROLOGY (2009)
Perls-speaks-NONMEM (PsN) - a Perl module for NONMEM related programming
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Quantitative justification for target concentration intervention - parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides
I Matthews et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Population pharmacokinetics of clofarabine, a second-generation nucleoside analogy, in pediatric patients with acute leukemia
PL Bonate et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Developmental pharmacology - Drug disposition, action, and therapy in infants and children
GL Kearns et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors
DR Mould et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Share Paper
